LINCOLN COUNTY CANCER PROFILE A fact sheet from the Cancer Data Registry of Idaho, Idaho Hospital Association. Cancer Incidence 2011-2015 Cancer Mortality 2012-2016 BRFSS 2011-2016 CANCER Cancer is a group of more than 100 different diseases, each characterized by uncontrolled growth and spread of abnormal cells. Cancer risk increases with age and varies by gender and race. As the average age of the population increases, the incidence of cancer will increase as well. It is generally accepted that 65-80% of all cancers are related to personal lifestyle or environmental factors, such as smoking and diet, and are therefore preventable. Other factors such as age, gender, and family history of specific cancers are also associated with cancer and aid in the identification of people at high risk. For some cancers, effective treatment is available. For these cancers, early detection can save lives. For example, there is convincing evidence that screening for colorectal cancer reduces mortality in adults aged 50 to 75 years. Through improved prevention, early detection, and treatment, opportunities exist to lessen the burden of cancer in Idaho. RISK FACTORS AND INTERVENTIONS Aging: Because the population is aging, the number of new cancer cases and cancer deaths that occur each year will continue to increase unless the trend is reversed by significant improvements in prevention, early detection, and treatment. Smoking: Smoking and the use of smokeless tobacco are responsible for the majority of all cancers of the lung, trachea, bronchus, larynx, pharynx, oral cavity, and esophagus. Smoking is the leading cause of preventable death in the United States. Diet: The U.S. Department of Agriculture recommends the following dietary guidelines for managing a healthy diet: eat a variety of foods; maintain a healthy weight; choose a diet with plenty of fruits, vegetables, and whole-grain products; limit the use of sugar, sodium (salt), solid fats, and refined grains; and minimize alcoholic beverage consumption. Screening: Early detection is extremely important for those cancers that can be cured and which can be discovered early. FOR MORE INFORMATION Cancer Data Registry of Idaho 615 N. 7 th Street P.O. Box 1278 Boise, ID 83701 208-489-1380 https://www.idcancer.org National Cancer Institute Cancer Information Services 1-800-4CANCER https://www.cancer.gov/contact/contact -center American Cancer Society 2676 S. Vista Avenue Boise, ID 83705 208-343-4609 https://www.cancer.org 1
CANCER INCIDENCE 2011-2015 During the five-year period 2011-2015, 38,676 cases of invasive cancer were diagnosed among residents of the state of Idaho, 124 among Lincoln County residents. It is estimated that almost one in two Idahoans will develop cancer during their lifetime. Cancer Incidence 2011-2015 Lincoln County State of Idaho All Sites/Types 124 38,676 Female Breast 16 5,487 Prostate 24 5,021 Lung & Bronchus 8 4,493 Colorectal 11 3,151 The table, CANCER INCIDENCE 2011-2015, COMPARISON BETWEEN LINCOLN COUNTY AND THE REMAINDER OF THE STATE OF IDAHO, shows for Lincoln County the number of observed cases, person-years, crude rates, age and sexadjusted rates, expected number of cases based upon age and sex-specific rates in the remainder of Idaho, and p-values for tests comparing the number of observed and expected cases. The table also shows the number of observed cases, personyears, and crude rates for the remainder of the state of Idaho. Comparisons were made for all cancers combined, 23 invasive cancer types, in situ breast cancer, non-malignant brain and other central nervous system tumors, and pediatric cancer. Separate comparisons for males, females, and both sexes combined are included. As the table shows, the crude rate of invasive cancer incidence in Lincoln County was 470.9 cases per 100,000 person-years for the years 2011-2015. Compared with the crude incidence rate for the remainder of Idaho (478.8), this gives an estimate of the burden of disease in Lincoln County. The age- and sex-adjusted incidence rate of invasive cancer in Lincoln County, all sites combined, was 517.0 cases per 100,000 persons per year for the years 2011-2015. There were more cases of cancer in Lincoln County (124) than expected (114.8) based upon rates in the remainder of the state, but the difference was not statistically significant. There are many reasons why cancer incidence rates differ by county, related to smoking, other personal behaviors, socioeconomic status, and other factors. CANCER MORTALITY 2012-2016 In 2008 cancer became the leading cause of death in Idaho. From 2012-2016, 13,799 persons in Idaho died from cancer, 37 in Lincoln County. The majority of cancer deaths are from five primary sites: lung, colon, pancreas, female breast, and prostate. Mortality 2012-2016 Lincoln County State of Idaho All Deaths 193 63,430 Cancer Deaths % of All Deaths 37 19.2% 13,799 21.8% Lung & Bronchus 8 3,135 Colorectal 3 1,165 Pancreas 3 1,025 Female Breast 2 965 The table, CANCER MORTALITY 2012-2016, COMPARISON BETWEEN LINCOLN COUNTY AND THE REMAINDER OF THE STATE OF IDAHO, shows for Lincoln County the number of observed deaths, person-years, crude rates, age and sexadjusted rates, expected number of deaths based upon age and sex-specific rates in the remainder of Idaho, and p-values for tests comparing the number of observed and expected deaths. The table also shows the number of observed deaths, personyears, and crude rates for the remainder of the state of Idaho. Comparisons were made for all deaths, all cancer deaths, and 21 specific cancer types. Separate comparisons for males, females, and both sexes combined are included. The age- and sex-adjusted cancer mortality rate for Lincoln County, all sites combined, was 154.4 deaths per 100,000 persons per year for the years 2012-2016, compared with 168.8 for the remainder of the state. There were fewer cancer deaths in Lincoln County (37) than expected (40.5) based upon rates in the remainder of the state, but the difference was not statistically significant. Prostate 3 881 Statistical Note: Rates and percentages based upon 12 or fewer cases or deaths (numerator) should be interpreted with caution. Data Note: Mortality data may differ slightly from published official statistics from the Bureau of Vital Records and Health Statistics. 2
CANCER INCIDENCE 2011-2015 COMPARISON BETWEEN LINCOLN COUNTY AND THE REMAINDER OF THE STATE OF IDAHO Lincoln County Remainder of Idaho Cancer Observed Person Crude A.A.I. Expected Observed Person Crude Site/Type Sex Cases Years Rate (1) Rate (1,2) Cases (3) P-Value (4) Cases Years Rate (1) All Sites Combined Total 124 26,332 470.9 517.0 114.8 0.416 38,552 8,052,093 478.8 All Sites Combined Male 72 13,646 527.6 572.5 62.0 0.233 19,898 4,033,402 493.3 All Sites Combined Female 52 12,686 409.9 452.6 53.3 0.927 18,654 4,018,691 464.2 Bladder Total 5 26,332 19.0 21.1 5.6 1.000 1,888 8,052,093 23.4 Bladder Male 5 13,646 36.6 40.0 4.6 0.958 1,471 4,033,402 36.5 Bladder Female - 12,686 - - 1.2 0.621 417 4,018,691 10.4 Brain - malignant Total 4 26,332 15.2 16.0 1.8 0.204 566 8,052,093 7.0 Brain - malignant Male 3 13,646 22.0 23.1 1.1 0.202 344 4,033,402 8.5 Brain - malignant Female 1 12,686 7.9 8.3 0.7 0.975 222 4,018,691 5.5 Brain and other CNS - non-malignant Total - 26,332 - - 2.9 0.115 945 8,052,093 11.7 Brain and other CNS - non-malignant Male - 13,646 - - 1.0 0.727 320 4,033,402 7.9 Brain and other CNS - non-malignant Female - 12,686 - - 1.8 0.331 625 4,018,691 15.6 Breast Total 16 26,332 60.8 66.4 16.5 1.000 5,512 8,052,093 68.5 Breast Male - 13,646 - - 0.1 1.000 41 4,033,402 1.0 Breast Female 16 12,686 126.1 139.4 15.6 0.992 5,471 4,018,691 136.1 Breast - in situ Total 1 26,332 3.8 4.2 3.1 0.357 1,055 8,052,093 13.1 Breast - in situ Male - 13,646 - - 0.0 1.000 3 4,033,402 0.1 Breast - in situ Female 1 12,686 7.9 8.7 3.0 0.396 1,052 4,018,691 26.2 Cervix Female 1 12,686 7.9 8.4 0.7 1.000 240 4,018,691 6.0 Colorectal Total 11 26,332 41.8 45.8 9.4 0.675 3,140 8,052,093 39.0 Colorectal Male 8 13,646 58.6 63.4 5.1 0.293 1,638 4,033,402 40.6 Colorectal Female 3 12,686 23.6 26.2 4.3 0.762 1,502 4,018,691 37.4 Corpus Uteri Female 3 12,686 23.6 26.3 3.2 1.000 1,109 4,018,691 27.6 Esophagus Total 1 26,332 3.8 4.2 1.2 1.000 409 8,052,093 5.1 Esophagus Male 1 13,646 7.3 8.0 1.0 1.000 337 4,033,402 8.4 Esophagus Female - 12,686 - - 0.2 1.000 72 4,018,691 1.8 Hodgkin Lymphoma Total - 26,332 - - 0.6 1.000 206 8,052,093 2.6 Hodgkin Lymphoma Male - 13,646 - - 0.4 1.000 119 4,033,402 3.0 Hodgkin Lymphoma Female - 12,686 - - 0.3 1.000 87 4,018,691 2.2 Kidney and Renal Pelvis Total 5 26,332 19.0 20.9 4.2 0.814 1,408 8,052,093 17.5 Kidney and Renal Pelvis Male 3 13,646 22.0 24.0 2.8 1.000 899 4,033,402 22.3 Kidney and Renal Pelvis Female 2 12,686 15.8 17.5 1.4 0.851 509 4,018,691 12.7 Larynx Total 1 26,332 3.8 4.2 0.6 0.892 200 8,052,093 2.5 Larynx Male 1 13,646 7.3 8.0 0.5 0.808 166 4,033,402 4.1 Larynx Female - 12,686 - - 0.1 1.000 34 4,018,691 0.8 Leukemia Total 7 26,332 26.6 28.6 4.2 0.262 1,375 8,052,093 17.1 Leukemia Male 4 13,646 29.3 31.1 2.5 0.484 784 4,033,402 19.4 Leukemia Female 3 12,686 23.6 25.5 1.7 0.501 591 4,018,691 14.7 Liver and Bile Duct Total 2 26,332 7.6 8.3 1.9 1.000 628 8,052,093 7.8 Liver and Bile Duct Male - 13,646 - - 1.4 0.485 446 4,033,402 11.1 Liver and Bile Duct Female 2 12,686 15.8 17.7 0.5 0.187 182 4,018,691 4.5 Lung and Bronchus Total 8 26,332 30.4 33.9 13.1 0.188 4,485 8,052,093 55.7 Lung and Bronchus Male 7 13,646 51.3 56.2 7.2 1.000 2,318 4,033,402 57.5 Lung and Bronchus Female 1 12,686 7.9 8.9 6.1 0.033 << 2,167 4,018,691 53.9 Melanoma of the Skin Total 6 26,332 22.8 24.7 7.1 0.880 2,337 8,052,093 29.0 Melanoma of the Skin Male 2 13,646 14.7 15.6 4.3 0.394 1,356 4,033,402 33.6 Melanoma of the Skin Female 4 12,686 31.5 34.3 2.8 0.637 981 4,018,691 24.4 Myeloma Total - 26,332 - - 1.6 0.413 538 8,052,093 6.7 Myeloma Male - 13,646 - - 1.0 0.741 324 4,033,402 8.0 Myeloma Female - 12,686 - - 0.6 1.000 214 4,018,691 5.3 Non-Hodgkin Lymphoma Total 3 26,332 11.4 12.5 4.9 0.563 1,635 8,052,093 20.3 Non-Hodgkin Lymphoma Male 3 13,646 22.0 23.7 2.9 1.000 927 4,033,402 23.0 Non-Hodgkin Lymphoma Female - 12,686 - - 2.0 0.264 708 4,018,691 17.6 Oral Cavity and Pharynx Total 6 26,332 22.8 25.1 3.2 0.202 1,063 8,052,093 13.2 Oral Cavity and Pharynx Male 3 13,646 22.0 23.7 2.3 0.794 726 4,033,402 18.0 Oral Cavity and Pharynx Female 3 12,686 23.6 26.5 1.0 0.143 337 4,018,691 8.4 Ovary Female 1 12,686 7.9 8.7 1.5 1.000 510 4,018,691 12.7 Pancreas Total 4 26,332 15.2 16.8 3.4 0.890 1,156 8,052,093 14.4 Pancreas Male 2 13,646 14.7 15.9 2.0 1.000 632 4,033,402 15.7 Pancreas Female 2 12,686 15.8 17.7 1.5 0.867 524 4,018,691 13.0 Prostate Male 24 13,646 175.9 193.4 15.4 0.050 >> 4,997 4,033,402 123.9 Stomach Total 1 26,332 3.8 4.2 1.3 1.000 442 8,052,093 5.5 Stomach Male - 13,646 - - 0.9 0.801 294 4,033,402 7.3 Stomach Female 1 12,686 7.9 8.8 0.4 0.685 148 4,018,691 3.7 Testis Male 2 13,646 14.7 15.4 0.8 0.410 261 4,033,402 6.5 Thyroid Total 1 26,332 3.8 4.0 3.9 0.196 1,274 8,052,093 15.8 Thyroid Male - 13,646 - - 0.9 0.791 292 4,033,402 7.2 Thyroid Female 1 12,686 7.9 8.4 2.9 0.425 982 4,018,691 24.4 Pediatric Age 0 to 19 Total 1 8,949 11.2 11.3 1.6 1.000 419 2,360,820 17.7 Pediatric Age 0 to 19 Male 1 4,665 21.4 21.8 0.8 1.000 221 1,207,941 18.3 Pediatric Age 0 to 19 Female - 4,284 - - 0.7 0.964 198 1,152,879 17.2 Notes: 1. Rates are expressed as the number of cases per 100,000 persons per year (person-years). 2. Age and sex-adjusted incidence (A.A.I.) rates for county use age and sex-specific crude rates for the remainder of the state as standard. 3. Expected cases are based upon age and sex-specific rates for the remainder of the state of Idaho (compare to observed). 4. P-values compare observed and expected cases, are two tailed, based upon the Poisson probability distribution. "<<" denotes significantly fewer cases observed than expected, ">>" denotes significantly more cases observed than expected (p=.05). Statistical Note: Rates based upon 12 or fewer cases (numerator) should be interpreted with caution. 3
CANCER MORTALITY 2012-2016 COMPARISON BETWEEN LINCOLN COUNTY AND THE REMAINDER OF THE STATE OF IDAHO Lincoln County Remainder of Idaho Cause of Death Observed Person Crude A.A.M. Expected Observed Person Crude Cancer Site/Type Sex Deaths Years Rate (1) Rate (1,2) Deaths (3) P-Value (4) Deaths Years Rate (1) All Causes of Death Total 193 26,462 729.3 795.5 188.2 0.748 63,237 8,150,960 775.8 All Causes of Death Male 100 13,671 731.5 771.4 104.1 0.735 32,791 4,083,431 803.0 All Causes of Death Female 93 12,791 727.1 814.5 85.5 0.442 30,446 4,067,529 748.5 All Malignant Cancers Total 37 26,462 139.8 154.4 40.5 0.657 13,762 8,150,960 168.8 All Malignant Cancers Male 20 13,671 146.3 157.5 23.1 0.601 7,439 4,083,431 182.2 All Malignant Cancers Female 17 12,791 132.9 149.2 17.7 0.992 6,323 4,067,529 155.5 Bladder Total - 26,462 - - 1.1 0.650 382 8,150,960 4.7 Bladder Male - 13,671 - - 0.9 0.812 286 4,083,431 7.0 Bladder Female - 12,791 - - 0.3 1.000 96 4,067,529 2.4 Brain and Other Nervous System Total 1 26,462 3.8 4.1 1.4 1.000 465 8,150,960 5.7 Brain and Other Nervous System Male 1 13,671 7.3 7.9 0.9 1.000 295 4,083,431 7.2 Brain and Other Nervous System Female - 12,791 - - 0.5 1.000 170 4,067,529 4.2 Breast Total 2 26,462 7.6 8.3 2.9 0.904 971 8,150,960 11.9 Breast Male - 13,671 - - 0.0 1.000 8 4,083,431 0.2 Breast Female 2 12,791 15.6 17.5 2.7 0.982 963 4,067,529 23.7 Cervix Female - 12,791 - - 0.2 1.000 77 4,067,529 1.9 Colorectal Total 3 26,462 11.3 12.5 3.4 1.000 1,162 8,150,960 14.3 Colorectal Male 1 13,671 7.3 7.8 2.0 0.807 643 4,083,431 15.7 Colorectal Female 2 12,791 15.6 17.5 1.5 0.855 519 4,067,529 12.8 Corpus Uteri Female 1 12,791 7.8 8.8 0.4 0.592 125 4,067,529 3.1 Esophagus Total - 26,462 - - 1.2 0.615 403 8,150,960 4.9 Esophagus Male - 13,671 - - 1.0 0.750 318 4,083,431 7.8 Esophagus Female - 12,791 - - 0.2 1.000 85 4,067,529 2.1 Hodgkin Lymphoma Total - 26,462 - - 0.1 1.000 25 8,150,960 0.3 Hodgkin Lymphoma Male - 13,671 - - 0.0 1.000 12 4,083,431 0.3 Hodgkin Lymphoma Female - 12,791 - - 0.0 1.000 13 4,067,529 0.3 Kidney Total 2 26,462 7.6 8.3 1.0 0.552 351 8,150,960 4.3 Kidney Male 1 13,671 7.3 7.9 0.7 1.000 231 4,083,431 5.7 Kidney Female 1 12,791 7.8 8.8 0.3 0.569 120 4,067,529 3.0 Larynx Total - 26,462 - - 0.2 1.000 61 8,150,960 0.7 Larynx Male - 13,671 - - 0.2 1.000 50 4,083,431 1.2 Larynx Female - 12,791 - - 0.0 1.000 11 4,067,529 0.3 Leukemia Total 1 26,462 3.8 4.1 1.7 1.000 567 8,150,960 7.0 Leukemia Male 1 13,671 7.3 7.9 1.0 1.000 336 4,083,431 8.2 Leukemia Female - 12,791 - - 0.7 1.000 231 4,067,529 5.7 Liver and Bile Duct Total - 26,462 - - 1.6 0.404 542 8,150,960 6.6 Liver and Bile Duct Male - 13,671 - - 1.1 0.647 362 4,083,431 8.9 Liver and Bile Duct Female - 12,791 - - 0.5 1.000 180 4,067,529 4.4 Lung and Bronchus Total 8 26,462 30.2 33.7 9.1 0.885 3,127 8,150,960 38.4 Lung and Bronchus Male 6 13,671 43.9 47.9 5.1 0.820 1,678 4,083,431 41.1 Lung and Bronchus Female 2 12,791 15.6 17.7 4.0 0.469 1,449 4,067,529 35.6 Melanoma of the Skin Total 1 26,462 3.8 4.1 0.9 1.000 307 8,150,960 3.8 Melanoma of the Skin Male 1 13,671 7.3 7.8 0.6 0.927 198 4,083,431 4.8 Melanoma of the Skin Female - 12,791 - - 0.3 1.000 109 4,067,529 2.7 Myeloma Total - 26,462 - - 0.9 0.821 302 8,150,960 3.7 Myeloma Male - 13,671 - - 0.5 1.000 176 4,083,431 4.3 Myeloma Female - 12,791 - - 0.4 1.000 126 4,067,529 3.1 Non-Hodgkin Lymphoma Total 4 26,462 15.1 16.8 1.6 0.158 547 8,150,960 6.7 Non-Hodgkin Lymphoma Male 3 13,671 21.9 23.9 0.9 0.139 306 4,083,431 7.5 Non-Hodgkin Lymphoma Female 1 12,791 7.8 8.8 0.7 0.978 241 4,067,529 5.9 Oral Cavity and Pharynx Total - 26,462 - - 0.6 1.000 202 8,150,960 2.5 Oral Cavity and Pharynx Male - 13,671 - - 0.4 1.000 138 4,083,431 3.4 Oral Cavity and Pharynx Female - 12,791 - - 0.2 1.000 64 4,067,529 1.6 Ovary Female - 12,791 - - 1.1 0.642 405 4,067,529 10.0 Pancreas Total 3 26,462 11.3 12.6 3.0 1.000 1,022 8,150,960 12.5 Pancreas Male 1 13,671 7.3 8.0 1.7 0.968 562 4,083,431 13.8 Pancreas Female 2 12,791 15.6 17.7 1.3 0.731 460 4,067,529 11.3 Prostate Male 3 13,671 21.9 23.3 2.8 1.000 878 4,083,431 21.5 Stomach Total 2 26,462 7.6 8.3 0.6 0.248 205 8,150,960 2.5 Stomach Male 1 13,671 7.3 7.9 0.4 0.674 132 4,083,431 3.2 Stomach Female 1 12,791 7.8 8.8 0.2 0.370 73 4,067,529 1.8 Notes: 1. Rates are expressed as the number of cases per 100,000 persons per year (person-years). 2. Age and sex-adjusted mortality (A.A.M.) rates for county use age and sex-specific crude rates for the remainder of the state as standard. 3. Expected cases are based upon age and sex-specific rates for the remainder of the state of Idaho (compare to observed). 4. P-values compare observed and expected cases, are two tailed, based upon the Poisson probability distribution. "<<" denotes significantly fewer cases observed than expected, ">>" denotes significantly more cases observed than expected (p=.05). Statistical Notes: Rates based upon 12 or fewer cases (numerator) should be interpreted with caution. Mortality statistics presented differ from BVRHS official statistics due to differences in methodology. Data Source: Bureau of Vital Records and Health Statistics (BVRHS), Division of Public Health, Idaho Department of Health and Welfare, 2017. 4
Cancer Screening and Risk Factors The Bureau of Vital Records and Health Statistics (BVRHS), Division of Public Health, Idaho Department of Health and Welfare, under a cooperative agreement with the Centers for Disease Control and Prevention, has conducted telephone Behavioral Risk Factor Surveys (BRFS) since 1984 of random samples of adult Idahoans to measure population prevalences of risk factors for the major causes of death, including cancer. The BVRHS provided data sets containing Behavioral Risk Factor Surveillance System (BRFSS) data from 2011 through 2016 to CDRI staff, who performed the analyses reported in these County Profiles. Analysis weights were poststratified to 2016 population estimates by age group, sex, and county, beginning with the BRFSS raked weights. Not all questions were asked in all years. A minimum of 50 respondents was required to generate county-level statistics. Results may differ from IDHW reports due to differences in methods. The cancer screening and risk factor measures were selected to assist in monitoring Comprehensive Cancer Alliance for Idaho objectives. Wald log-linear chi-square statistics were used to test for independence of the selected measures and other variables such as age and race, taking into account the complex survey design. Cancer Screening and Risk Factor Prevalence Estimates, 2011-2016 State of Idaho HD 1 HD 2 HD 3 HD 4 HD 5 HD 6 HD 7 Lincoln County Access to Care Health Insurance, Age <65 (2014-2016) 81.4% 80.1% 84.9% 73.9% 86.5% 73.3% 83.4% 83.5%. Not See Doctor Due to Cost Past Year (2014-2016) 14.3% 14.0% 10.9% 19.0% 13.2% 14.7% 13.0% 13.8% 13.2% Cancer Screening Mammogram Past 2 Years, Age 50-74 (2014, 2016) 67.0% 66.4% 69.7% 64.0% 71.3% 61.8% 63.1% 67.8%. Pap Test Past 3 Years, Cervix Intact Age 21-65 (2012, 2014, 2016) 75.2% 75.8% 80.1% 69.0% 78.9% 72.9% 75.7% 72.0%. Colorectal Cancer Screening, Age 50-75 (2012, 2014, 2016) 62.3% 62.4% 65.4% 57.8% 66.5% 59.2% 59.7% 61.0%. Tobacco Use Current Smoker (2014-2016) 14.7% 17.5% 14.8% 18.8% 12.1% 17.5% 14.2% 10.1% 13.8% Current Smokeless Tobacco User, Males (2012-2016) 9.6% 10.2% 15.4% 11.3% 8.6% 10.1% 7.8% 7.3%. Other Cancer-Related Sunburn in Previous 12 Months (2016) 24.4% 25.6% 24.6% 18.6% 21.9% 26.4% 29.6% 30.8%. Artificial Tanning Appliance Use (2011, 2014, 2016) 4.4% 5.6% 3.3% 3.3% 3.5% 4.2% 5.7% 6.8% 6.1% Weight Classification by Body Mass Index, Age 20+ (2013-2016) 32.7% 34.1% 35.5% 26.6% 36.5% 29.5% 31.1% 32.2% 34.4% Meet Physical Activity Guidelines (2011, 2013, 2015) 21.5% 21.1% 18.2% 19.0% 25.7% 19.1% 20.6% 19.6% 22.4% Home Ever Tested for Radon (2014, 2016) 18.6% 25.5% 13.7% 12.6% 20.2% 16.1% 20.4% 18.5%. Access to Care Health Insurance 2014-2016 Statewide, 81.4% of adults aged 18-64 reported having health care coverage. Health care coverage differed significantly by race/ethnicity, with 84.3% of white non-hispanics, compared to 61.3% of Hispanics and 87.1% of Native Americans, having health insurance. Spanish-speaking respondents were significantly less likely to be insured (34.5%) than Englishspeaking respondents (83.2%). Health care coverage differed significantly by age of respondent, with 77.8% of persons aged 18-29, and 86.6% of persons aged 50-64, having health insurance. Health care coverage differed significantly by county, with a range of 63.7% (Jerome County) to 94.3% (Caribou County) having health insurance. Not See Doctor Due to Cost Past Year 2014-2016 Statewide, 14.3% of adults aged 18+ reported they needed to see a doctor but could not because of cost sometime in the past 12 months. Inability to see a doctor due to cost differed significantly by race/ethnicity (13.3% of white non-hispanics, 22.9% of Hispanics, and 15.9% of Native Americans). Inability to see a doctor due to cost differed significantly by annual household income (29.1% for less than $15,000, 7.1% for greater than $50,000). Inability to see a doctor due to cost differed significantly by county, with a range of 3.9% (Butte County) to 21.0% (Jerome County). ** Current for colorectal cancer screening means a blood stool test in the past year, sigmoidoscopy in the past 5 years and blood stool test in the past 3 years, or a colonoscopy in the past 10 years. Cancer Screening Mammogram 2014, 2016 Statewide, 67.0% of women aged 50-74 reported having a mammogram in the past 2 years. Insured women were about twice as likely to have had a mammogram in the past 2 years (70.4% versus 32.8%). Mammography rates differed significantly by county, with a range in screening of 62.7% (Bingham County) to 76.0% (Nez Perce County). In 2016, Idaho ranked 50 th among states and the District of Columbia for mammography screening rates among women aged 50-74 and 51 st among ages 40+. Pap Test 2012, 2014, 2016 Statewide, 75.2% of women aged 21-65 (with intact cervix) reported having a Pap test in the past 3 years. Women with health insurance were significantly more likely to have timely Pap screening than uninsured women (78.0% versus 64.9% screened in the past 3 years). Pap screening differed significantly by county, with a range of 59.6% (Madison County) to 89.5% (Nez Perce County). In 2016, Idaho ranked 50 th among states and the District of Columbia for Pap screening rate. Colorectal Cancer Screening 2012, 2014, 2016 Statewide, 62.3% of adults aged 50-75 reported receiving colorectal cancer screening based on the most recent guidelines.** Persons with health insurance were over twice as likely to be current for colorectal cancer screening. In 2016, Idaho ranked 44 th among states and the District of Columbia in the percentage of adults aged 50-75 and older who reported being current with colorectal cancer screening recommendations. 5
Cancer Screening and Risk Factors Tobacco Use Current Smoking 2014-2016 Statewide, 14.7% of adults aged 18 and older were current smokers. Smoking prevalence differed significantly by age of respondent, with 19.0% of persons aged 30-39, and 8.2% of persons aged 65 and older, reporting current smoking. Smoking prevalence was lower among white non-hispanics (14.8%) than among Native Americans (28.3%). Smoking prevalence differed significantly by county, with a range of 3.8% (Madison County) to 32.6% (Washington County). Counties with higher rates of current smoking had higher rates of lung cancer. Smokeless Tobacco Use, Males 2012-2016 Statewide, 9.6% of males aged 18 and older were current users of smokeless tobacco. Smokeless tobacco use differed significantly by age group, ranging from 13.4% of males aged 30-39 to 4.2% of males aged 65 and older. Smokeless tobacco use differed significantly by county, with a range of 2.2% (Franklin County) to 24.5% (Custer County). Counties with higher rates of smokeless tobacco use had higher rates of oral cavity & pharynx cancer. Other Cancer-Related Sun Exposure 2016 Statewide, 24.4% of adults aged 18 and older reported having sunburn in the past 12 months. Sunburn rates were higher for white non-hispanics (26.1%) than for Hispanics (12.3%) or Native Americans (19.4%). Sunburn rates differed significantly by age group, with 38.3% of persons aged 18-29 and 6.0% of persons aged 65 and older having sunburn in the past 12 months. Sunburn rates differed significantly by county, with a range of 11.8% (Jerome County) to 47.0% (Minidoka County) having sunburn in the past 12 months. Weight Classification by Body Mass Index 2013-2016 Statewide, 32.7% of adults aged 20 and older were in the healthy weight range as measured by body mass index (BMI 18.5-24.9). BMI differed significantly by race/ethnicity, with 33.4% of white non-hispanics, compared to 25.9% of Hispanics and 27.0% of Native Americans, being in the healthy weight range. Males (25.8%) were significantly less likely to be in the healthy weight range than females (39.5%). BMI differed significantly by age of respondent, with 43.5% of persons aged 18-29, and 27.2% of persons aged 50-64, being in the healthy weight range. BMI differed significantly by county, with a range of 21.0% (Gem County) to 46.9% (Blaine County) of adults being in the healthy weight range. Counties with higher percentages of adults in the healthy weight range had significantly lower rates of colorectal cancer (p=.011). Physical Activity 2011, 2013, 2015 Statewide, 21.5% of adults aged 18 and older met aerobic and strength physical activity guidelines during the past month or week. Physical activity differed significantly by age of respondent, with 25.2% of persons aged 18-29, and 18.8% of persons aged 50-64, meeting guidelines. The percentage of adults meeting physical activity guidelines differed significantly by county, with a range of 7.6% (Oneida County) to 29.8% (Blaine County). Home Radon Testing 2014, 2016 Statewide, 18.6% of adults have ever tested their house for radon. Radon test usage varied significantly by race/ethnicity, with 20.2% of white non-hispanics, 4.9% of Hispanics, and 23.2% of Native Americans having ever tested their house for radon. Radon test usage was higher for persons aged 50-64 than for younger persons. Home radon testing differed significantly by county, with a range of 6.9% (Cassia County) to 50.2% (Blaine County). Artificial Tanning Appliance Use 2011, 2014, 2016 Statewide, 4.4% of adults aged 18 and older reported using an artificial tanning appliance, such as a tanning bed, in the past 12 months. Females (6.8%) were significantly more likely than males (2.1%) to have used an artificial tanning appliance in the past 12 months. Tanning appliance use differed significantly by age group, with 8.7% of persons aged 18-29 and 0.9% of persons aged 65 and older, using an appliance in the past 12 months. Tanning appliance use differed by county, with a range of less than 1% (Oneida, Power, and Valley Counties) to over 9% (Bear Lake, Fremont, and Madison Counties) using an artificial tanning appliance in the past 12 months. 6